// App-Quantinova.ai

: The Boston Naming Test identifies presymptomatic anomia in MAPT mutation carriers

Researchers

Presenter

  • Arabella Bouzigues

Principal Investigators

  • Lucy L Russell

  • Georgia Peakman

  • Rhian S Convery

  • Caroline V Greaves

  • Martina Bocchetta

  • Emily G Todd

  • David M Cash

  • Jonathan D Rohrer

Medical Centers

  • Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.

  • 4. UK Dementia Research Institute, Queen Square Institute of Neurology, University College London,

  • Dementia Research Centre at UCL Queen Square Institute of Neurology

  • 4. UK Dementia Research Institute, Queen Square Institute of Neurology, University College London,

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Central Nervous System (CNS)

Disease

  • Frontotemporal dementia

Biomarkers

  • Granulin precursor

  • Tau protein

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A